HY-151462-10mg
|
MedChemexpress LLC
|
RP-6685 [CAS 2832047-80-8]
|
|
Cancer-programmed cell death
|
|
HY-151462-100mg
|
MedChemexpress LLC
|
RP-6685 [CAS 2832047-80-8]
|
|
Cancer-programmed cell death
|
|
HY-151462-25mg
|
MedChemexpress LLC
|
RP-6685 [CAS 2832047-80-8]
|
|
Cancer-programmed cell death
|
|
HY-151462-5mg
|
MedChemexpress LLC
|
RP-6685 [CAS 2832047-80-8]
|
|
Cancer-programmed cell death
|
|
HY-151462-50mg
|
MedChemexpress LLC
|
RP-6685 [CAS 2832047-80-8]
|
|
Cancer-programmed cell death
|
|
HY-151462-1mL
|
MedChemexpress LLC
|
RP-6685 [CAS 2832047-80-8] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-16582-10mg
|
MedChemexpress LLC
|
Sonidegib (diphosphate) [CAS 1218778-77-8]
|
|
Cancer-programmed cell death
|
|
HY-16582-100mg
|
MedChemexpress LLC
|
Sonidegib (diphosphate) [CAS 1218778-77-8]
|
|
Cancer-programmed cell death
|
|
HY-16582-5mg
|
MedChemexpress LLC
|
Sonidegib (diphosphate) [CAS 1218778-77-8]
|
|
Cancer-programmed cell death
|
|
HY-16582-50mg
|
MedChemexpress LLC
|
Sonidegib (diphosphate) [CAS 1218778-77-8]
|
|
Cancer-programmed cell death
|
|
HY-16582-1mL
|
MedChemexpress LLC
|
Sonidegib (diphosphate) [CAS 1218778-77-8] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-16582A-10mg
|
MedChemexpress LLC
|
Sonidegib [CAS 956697-53-3]
|
|
Cancer-programmed cell death
|
|
HY-16582A-100mg
|
MedChemexpress LLC
|
Sonidegib [CAS 956697-53-3]
|
|
Cancer-programmed cell death
|
|
HY-16582A-5mg
|
MedChemexpress LLC
|
Sonidegib [CAS 956697-53-3]
|
|
Cancer-programmed cell death
|
|
HY-16582A-50mg
|
MedChemexpress LLC
|
Sonidegib [CAS 956697-53-3]
|
|
Cancer-programmed cell death
|
|
HY-16582A-1mL
|
MedChemexpress LLC
|
Sonidegib [CAS 956697-53-3] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-10596-10mg
|
MedChemexpress LLC
|
BMS-688521 [CAS 893397-44-9]
|
|
COVID-19-immunoregulation
|
|
HY-10596-100mg
|
MedChemexpress LLC
|
BMS-688521 [CAS 893397-44-9]
|
|
COVID-19-immunoregulation
|
|
HY-10596-25mg
|
MedChemexpress LLC
|
BMS-688521 [CAS 893397-44-9]
|
|
COVID-19-immunoregulation
|
|
HY-10596-5mg
|
MedChemexpress LLC
|
BMS-688521 [CAS 893397-44-9]
|
|
COVID-19-immunoregulation
|
|
HY-10596-50mg
|
MedChemexpress LLC
|
BMS-688521 [CAS 893397-44-9]
|
|
COVID-19-immunoregulation
|
|
HY-10596-1mL
|
MedChemexpress LLC
|
BMS-688521 [CAS 893397-44-9] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-136527-1mg
|
MedChemexpress LLC
|
BMS-986251 [CAS 2460133-35-9]
|
|
COVID-19-immunoregulation
|
|
HY-136527-10mg
|
MedChemexpress LLC
|
BMS-986251 [CAS 2460133-35-9]
|
|
COVID-19-immunoregulation
|
|
HY-136527-100mg
|
MedChemexpress LLC
|
BMS-986251 [CAS 2460133-35-9]
|
|
COVID-19-immunoregulation
|
|